跳至主要内容
临床试验/IRCT20200324046852N1
IRCT20200324046852N1已完成2 期

Evaluation of efficacy of pharmacotherapy treatment of COVID- 19 infection using oral Levamisole and Formoterol+Budesonide inhaler and comparison of this treatment protocol with standard national treatment of the disease

Fasa University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • COVID-19 positive patients with positive, PCR and chest CT scan

排除标准

  • Patients with sever respiratory problems including patients with:1. Spo2<60%2. Severe respiratory distress3. Heamodynamic instabilitty 4. Acid base disturbance 5. Severe Anemia
  • Patients with hepatic diseases
  • Patients with Nervous system diseases

研究者

发起方
Fasa University of Medical Sciences

相似试验